Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia

www.lmu.de | UB | Browse | Help

Advanced Search

Deutsch

Advanced Search

Bornhäuser, Martin; Schliemann, Christoph; Schetelig, Johannes; Röllig, Christoph; Kramer, Michael; Glass, Bertram; Platzbecker, Uwe; Burchert, Andreas; Hänel, Mathias; Müller, Lutz P.; Klein, Stefan; Bug, Gesine; Beelen, Dietrich; Rösler, Wolf; Schäfer-Eckart, Kerstin; Schmid, Christoph; Jost, Edgar; Lenz, Georg; Tischer, Johanna; Spiekermann, Karsten ORCID: https://orcid.org/0000-0002-5139-4957; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Serve, Hubert; Stölzel, Friedrich; Alakel, Nael; Middeke, Jan Moritz; Thiede, Christian; Ehninger, Gerhard; Berdel, Wolfgang E. und Stelljes, Matthias (2023): Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia. In: JAMA Oncology, Vol. 9, No. 4: pp. 519-526

Full text not available from 'Open Access LMU'.

DOI: 10.1001/jamaoncol.2022.7605

Item Type:	Journal article
Faculties:	Medicine > Institute for Medical Information Processing, Biometry and Epidemiology
Subjects:	600 Technology > 610 Medicine and health
ISSN:	2374-2437
Language:	English
Item ID:	94641
Date Deposited:	15. Feb 2023 09:57
Last Modified:	23. Jun 2023 07:44

Actions (login required)

View Item